StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CYCNKorsana Biosciences, Inc.
stockpulse.co.kr
Nasdaq
$25.00▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $108.3MShares out 4.3M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

33
  • 9.18After-hours26.09.19 08:20
    SCHEDULE 13GOwnership#●●●

    Korsana Biosciences, Inc.

    General Atlantic and its affiliated investment entities have filed a Schedule 13G to report their joint beneficial ownership in Korsana Biosciences, Inc. This filing formalizes the group's status as a major shareholder and discloses their equity position in the company.…more

    $25.00+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.18After-hours26.09.19 05:49
    144Ownership

    Korsana Biosciences, Inc.

    Errol B. DeSouza, an insider at Korsana Biosciences, Inc., has filed a Form 144 to report a proposed sale of company securities. This filing serves as a formal notification of the insider's intent to dispose of shares.…more

    $25.00+0.00%vs prev close
    View filingShare
  • 9.16Pre-market26.09.16 20:55
    SCHEDULE 13GOwnership

    Korsana Biosciences, Inc.

    Wellington Biomedical Innovation Master Investors (Cayman) II L.P. has filed a Schedule 13G, reporting a beneficial ownership of more than 5% in Korsana Biosciences, Inc. This filing formalizes the investor's stake in the company and may influence future corporate governance and shareholder structure.…more

    $25.00+0.00%vs prev close
    View filingShare

32 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 8.25After-hours26.08.26 05:18
    #●●●

    Cyclerion Therapeutics Sets September 4 Record Date for CVR Distribution in Korsana Merger…more

    Cyclerion Therapeutics has set September 4 as the record date for the distribution of Contingent Value Rights (CVRs) to shareholders in connection with its planned merger with Korsana Biosciences. This action is part of the formal process to finalize shareholder rights under the merger agreement.…more

    $25.00+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga